# OptimizeRx Corp: filings

OPRX · Nasdaq · CIK 1448431 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/oprx.md) · [Financials](/companies/oprx/financials.md) · [Filings](/companies/oprx/filings.md) · [Insiders](/companies/oprx/insiders.md)

## Reports and events: 449 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 399, 8-K 322, 10-Q 53, 3 31, SC 13G/A 25, SC 13G 24, 10-K 18, CORRESP 15, SC 13D/A 12, 4/A 11, UPLOAD 10, 8-K/A 9, EFFECT 9, DEF 14A 8, S-1/A 8, S-8 8, 424B3 6, 424B5 6, SCHEDULE 13G/A 6, 144 5, NT 10-Q 5, SC 13D 5, 10-Q/A 4, D 4, S-1 4, SCHEDULE 13G 4, 10-K/A 3, ARS 3, NT 10-K 3, DEFA14A 2, POS AM 2, S-3 2, S-8 POS 2, SCHEDULE 13D/A 2, 8-A12B 1, 8-A12G 1, CERT 1, DEF 14C 1, DFAN14A 1, S-3/A 1, S-3ASR 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 20:06 ET | [10-Q](/filings/0001448431-26-000016.md) | Quarterly report, period 2026-06-30 | 0001448431-26-000016 |
| 2026-08-12 | 20:07 ET | [8-K](/filings/0001448431-26-000014.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001448431-26-000014 |
| 2026-06-12 | 20:10 ET | [8-K](/filings/0001213900-26-068272.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-068272 |
| 2026-06-05 | 20:10 ET | [8-K](/filings/0001213900-26-065810.md) | 5.02 Departure or appointment of officers or directors | 0001213900-26-065810 |
| 2026-05-13 | 20:04 ET | [10-Q](/filings/0001448431-26-000011.md) | Quarterly report, period 2026-03-31 | 0001448431-26-000011 |
| 2026-05-12 | 20:07 ET | [8-K](/filings/0001448431-26-000009.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001448431-26-000009 |
| 2026-04-30 | 11:15 ET | [DEF 14A](/filings/0001213900-26-049698.md) | Proxy statement, period 2026-06-09 | 0001213900-26-049698 |
| 2026-04-09 | 21:46 ET | [8-K](/filings/0001213900-26-041604.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-041604 |
| 2026-03-30 | 21:29 ET | [8-K](/filings/0001448431-26-000007.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001448431-26-000007 |
| 2026-03-12 | 20:03 ET | [10-K](/filings/0001448431-26-000005.md) | Annual report, period 2025-12-31 | 0001448431-26-000005 |
| 2026-03-05 | 21:09 ET | [8-K](/filings/0001448431-26-000002.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001448431-26-000002 |
| 2025-11-07 | 21:03 ET | [10-Q](/filings/0001448431-25-000020.md) | Quarterly report, period 2025-09-30 | 0001448431-25-000020 |
| 2025-11-06 | 21:13 ET | [8-K](/filings/0001448431-25-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001448431-25-000018 |
| 2025-08-19 | 11:44 ET | [8-K](/filings/0001213900-25-078162.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-078162 |
| 2025-08-08 | 20:02 ET | [10-Q](/filings/0001448431-25-000012.md) | Quarterly report, period 2025-06-30 | 0001448431-25-000012 |
| 2025-08-07 | 20:13 ET | [8-K](/filings/0001448431-25-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001448431-25-000010 |
| 2025-06-24 | 11:45 ET | [8-K](/filings/0001213900-25-056908.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-056908 |
| 2025-06-16 | 20:29 ET | [8-K](/filings/0001213900-25-054784.md) | 5.07 Shareholder vote results | 0001213900-25-054784 |
| 2025-05-13 | 20:04 ET | [10-Q](/filings/0001448431-25-000005.md) | Quarterly report, period 2025-03-31 | 0001448431-25-000005 |
| 2025-05-12 | 20:08 ET | [8-K](/filings/0001448431-25-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001448431-25-000003 |
| 2025-04-30 | 12:30 ET | [DEF 14A](/filings/0001213900-25-037114.md) | Proxy statement, period 2025-06-11 | 0001213900-25-037114 |
| 2025-04-21 | 18:47 ET | [SCHEDULE 13D/A](/filings/0000950170-25-056236.md) | Ownership report, active investor, amended | 0000950170-25-056236 |
| 2025-04-18 | 20:30 ET | [8-K](/filings/0001213900-25-033402.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-033402 |
| 2025-03-20 | 20:46 ET | [10-K](/filings/0001213900-25-025576.md) | Annual report, period 2024-12-31 | 0001213900-25-025576 |
| 2025-03-12 | 11:45 ET | [8-K](/filings/0001213900-25-022947.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-022947 |
| 2025-03-10 | 21:29 ET | [SCHEDULE 13D/A](/filings/0000950170-25-036537.md) | Ownership report, active investor, amended | 0000950170-25-036537 |
| 2025-03-10 | 11:45 ET | [8-K](/filings/0001213900-25-021923.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-021923 |
| 2025-02-05 | 16:41 ET | [SCHEDULE 13D](/filings/0000950170-25-014245.md) | Ownership report, active investor | 0000950170-25-014245 |
| 2025-01-10 | 21:05 ET | [8-K](/filings/0001213900-25-002644.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-002644 |
| 2024-12-23 | 13:50 ET | [8-K](/filings/0001213900-24-111528.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-111528 |
| 2024-11-14 | 20:30 ET | [10-Q](/filings/0001213900-24-098319.md) | Quarterly report, period 2024-09-30 | 0001213900-24-098319 |
| 2024-11-13 | 21:10 ET | [8-K](/filings/0001213900-24-097468.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-097468 |
| 2024-08-15 | 20:30 ET | [10-Q](/filings/0001213900-24-069700.md) | Quarterly report, period 2024-06-30 | 0001213900-24-069700 |
| 2024-08-08 | 20:25 ET | [8-K](/filings/0001213900-24-066641.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-066641 |
| 2024-06-07 | 20:00 ET | [8-K](/filings/0001213900-24-050753.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-24-050753 |
| 2024-05-15 | 21:01 ET | [10-Q](/filings/0001213900-24-043749.md) | Quarterly report, period 2024-03-31 | 0001213900-24-043749 |
| 2024-05-14 | 20:10 ET | [8-K](/filings/0001213900-24-042937.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-042937 |
| 2024-04-29 | 20:30 ET | [8-K](/filings/0001213900-24-037205.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-037205 |
| 2024-04-29 | 12:35 ET | [DEF 14A](/filings/0001213900-24-036855.md) | Proxy statement, period 2024-06-05 | 0001213900-24-036855 |
| 2024-04-18 | 20:30 ET | [8-K](/filings/0001213900-24-034128.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-034128 |
| 2024-04-15 | 20:41 ET | [10-K](/filings/0001213900-24-033000.md) | Annual report, period 2023-12-31 | 0001213900-24-033000 |
| 2024-04-02 | 20:05 ET | [8-K](/filings/0001213900-24-029318.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-029318 |
| 2024-03-11 | 21:04 ET | [8-K](/filings/0001213900-24-021461.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-021461 |
| 2024-01-26 | 21:00 ET | [8-K](/filings/0001213900-24-006959.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-006959 |
| 2024-01-05 | 22:19 ET | [8-K/A](/filings/0001213900-24-001616.md) | 9.01 Financial statements and exhibits | 0001213900-24-001616 |
| 2023-11-14 | 21:00 ET | [10-Q](/filings/0001213900-23-086885.md) | Quarterly report, period 2023-09-30 | 0001213900-23-086885 |
| 2023-11-06 | 12:15 ET | [8-K](/filings/0001213900-23-083645.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-083645 |
| 2023-10-25 | 20:00 ET | [8-K](/filings/0001013762-23-006625.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001013762-23-006625 |
| 2023-10-16 | 20:31 ET | [8-K](/filings/0001013762-23-004127.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001013762-23-004127 |
| 2023-08-14 | 20:31 ET | [10-Q](/filings/0001213900-23-067120.md) | Quarterly report, period 2023-06-30 | 0001213900-23-067120 |

Page 1 of 9. [Older](/companies/oprx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.